Details of Disease
General Information of Disease (ID: DISS1E36)
| Disease Name | Mucopolysaccharidosis type 2, attenuated form | |||||
|---|---|---|---|---|---|---|
| Synonyms |
mucopolysaccharidosis type IIB; mucopolysaccharidosis type 2, attenuated form; MPSIIB; MPS2B; mucopolysaccharidosis type II, attenuated form; mucopolysaccharidosis type 2B; Hunter syndrome type B; iduronate 2-sulfatase deficiency type B
|
|||||
| Definition |
Mucopolysaccharidosis type 2, attenuated form (MPS2att), the less severe form of MPS2, leads to a massive accumulation of glycosaminoglycans and a wide variety of symptoms including distinctive facies, short stature, cardiorespiratory and skeletal findings. It is differentiated from mucopolysaccharidosis type 2, severe form by the absence of cognitive decline.
|
|||||
| Disease Hierarchy | ||||||
| Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
This Disease Is Related to 1 DME Molecule(s)
|
|||||||||||||||||||||||||
|
This Disease Is Related to 1 DOT Molecule(s)
|
|||||||||||||||||||||||||
